- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x NA: SODIUM ION(Non-functional Binders)
- 12 x ACT: ACETATE ION(Non-functional Binders)
ACT.2: 7 residues within 4Å:- Chain A: A.245, V.248, E.249, K.267, I.268, A.271
- Ligands: NAD.5
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:E.249, A:A.271
ACT.3: 6 residues within 4Å:- Chain A: R.461, R.462, F.464, H.465
- Chain B: V.172, K.510
5 PLIP interactions:2 interactions with chain A, 3 interactions with chain B- Hydrogen bonds: A:F.464
- Salt bridges: A:H.465, B:K.510
- Hydrophobic interactions: B:V.172, B:K.510
ACT.12: 7 residues within 4Å:- Chain B: A.245, V.248, E.249, K.267, I.268, A.271
- Ligands: NAD.16
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:V.248, B:A.271
- Water bridges: B:K.267, B:K.267
ACT.13: 6 residues within 4Å:- Chain A: V.172, K.510
- Chain B: R.461, R.462, F.464, H.465
4 PLIP interactions:3 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:V.172, A:K.510
- Salt bridges: A:K.510, B:H.465
ACT.25: 7 residues within 4Å:- Chain C: A.245, V.248, E.249, K.267, I.268, A.271
- Ligands: NAD.28
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:E.249, C:A.271
ACT.26: 6 residues within 4Å:- Chain C: R.461, R.462, F.464, H.465
- Chain D: V.172, K.510
5 PLIP interactions:2 interactions with chain C, 3 interactions with chain D- Hydrogen bonds: C:F.464
- Salt bridges: C:H.465, D:K.510
- Hydrophobic interactions: D:V.172, D:K.510
ACT.35: 7 residues within 4Å:- Chain D: A.245, V.248, E.249, K.267, I.268, A.271
- Ligands: NAD.39
4 PLIP interactions:4 interactions with chain D- Hydrophobic interactions: D:V.248, D:A.271
- Water bridges: D:K.267, D:K.267
ACT.36: 6 residues within 4Å:- Chain C: V.172, K.510
- Chain D: R.461, R.462, F.464, H.465
4 PLIP interactions:3 interactions with chain C, 1 interactions with chain D- Hydrophobic interactions: C:V.172, C:K.510
- Salt bridges: C:K.510, D:H.465
ACT.48: 7 residues within 4Å:- Chain E: A.245, V.248, E.249, K.267, I.268, A.271
- Ligands: NAD.51
2 PLIP interactions:2 interactions with chain E- Hydrophobic interactions: E:E.249, E:A.271
ACT.49: 6 residues within 4Å:- Chain E: R.461, R.462, F.464, H.465
- Chain F: V.172, K.510
5 PLIP interactions:3 interactions with chain F, 2 interactions with chain E- Hydrophobic interactions: F:V.172, F:K.510
- Salt bridges: F:K.510, E:H.465
- Hydrogen bonds: E:F.464
ACT.58: 7 residues within 4Å:- Chain F: A.245, V.248, E.249, K.267, I.268, A.271
- Ligands: NAD.62
4 PLIP interactions:4 interactions with chain F- Hydrophobic interactions: F:V.248, F:A.271
- Water bridges: F:K.267, F:K.267
ACT.59: 6 residues within 4Å:- Chain E: V.172, K.510
- Chain F: R.461, R.462, F.464, H.465
4 PLIP interactions:3 interactions with chain E, 1 interactions with chain F- Hydrophobic interactions: E:V.172, E:K.510
- Salt bridges: E:K.510, F:H.465
- 6 x SER: SERINE(Non-covalent)
SER.4: 8 residues within 4Å:- Chain A: F.185, K.321, C.322, S.323, T.476, G.477, A.478, F.485
10 PLIP interactions:2 Ligand-Ligand interactions, 8 interactions with chain A- Hydrogen bonds: S.4, S.4, A:C.322, A:S.323, A:S.323, A:G.477, A:A.478
- Water bridges: A:E.137, A:E.137, A:A.478
SER.15: 7 residues within 4Å:- Chain B: F.185, C.322, S.323, T.476, G.477, A.478, F.485
9 PLIP interactions:8 interactions with chain B, 1 Ligand-Ligand interactions- Hydrogen bonds: B:C.322, B:S.323, B:S.323, B:G.477, B:A.478
- Water bridges: B:E.137, B:E.137, B:A.478, S.15
SER.27: 8 residues within 4Å:- Chain C: F.185, K.321, C.322, S.323, T.476, G.477, A.478, F.485
10 PLIP interactions:8 interactions with chain C, 2 Ligand-Ligand interactions- Hydrogen bonds: C:C.322, C:S.323, C:S.323, C:G.477, C:A.478, S.27, S.27
- Water bridges: C:E.137, C:E.137, C:A.478
SER.38: 7 residues within 4Å:- Chain D: F.185, C.322, S.323, T.476, G.477, A.478, F.485
9 PLIP interactions:8 interactions with chain D, 1 Ligand-Ligand interactions- Hydrogen bonds: D:C.322, D:S.323, D:S.323, D:G.477, D:A.478
- Water bridges: D:E.137, D:E.137, D:A.478, S.38
SER.50: 8 residues within 4Å:- Chain E: F.185, K.321, C.322, S.323, T.476, G.477, A.478, F.485
10 PLIP interactions:8 interactions with chain E, 2 Ligand-Ligand interactions- Hydrogen bonds: E:C.322, E:S.323, E:S.323, E:G.477, E:A.478, S.50, S.50
- Water bridges: E:E.137, E:E.137, E:A.478
SER.61: 7 residues within 4Å:- Chain F: F.185, C.322, S.323, T.476, G.477, A.478, F.485
9 PLIP interactions:1 Ligand-Ligand interactions, 8 interactions with chain F- Water bridges: S.61, F:E.137, F:E.137, F:A.478
- Hydrogen bonds: F:C.322, F:S.323, F:S.323, F:G.477, F:A.478
- 6 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.5: 29 residues within 4Å:- Chain A: I.180, A.181, P.182, W.183, N.184, I.189, K.207, P.208, A.209, E.210, G.240, E.241, G.244, A.245, F.258, T.259, G.260, S.261, V.264, I.268, E.288, T.289, G.290, C.322, E.417, F.419, L.445, F.485
- Ligands: ACT.2
17 PLIP interactions:17 interactions with chain A- Hydrophobic interactions: A:I.189, A:T.259
- Hydrogen bonds: A:A.181, A:A.181, A:W.183, A:K.207, A:E.210, A:G.240, A:E.241, A:S.261, A:T.289, A:E.417
- Water bridges: A:W.183, A:S.261, A:G.290, A:E.417, A:E.417
NAD.16: 29 residues within 4Å:- Chain B: I.180, A.181, P.182, W.183, N.184, I.189, K.207, P.208, A.209, E.210, G.240, E.241, G.244, A.245, F.258, T.259, G.260, S.261, V.264, I.268, E.288, T.289, G.290, C.322, E.417, F.419, L.445, F.485
- Ligands: ACT.12
18 PLIP interactions:18 interactions with chain B- Hydrophobic interactions: B:I.189, B:T.259
- Hydrogen bonds: B:A.181, B:A.181, B:W.183, B:K.207, B:E.210, B:G.240, B:S.261, B:T.289, B:E.417
- Water bridges: B:E.241, B:S.261, B:K.267, B:K.267, B:E.288, B:E.288, B:G.290
NAD.28: 29 residues within 4Å:- Chain C: I.180, A.181, P.182, W.183, N.184, I.189, K.207, P.208, A.209, E.210, G.240, E.241, G.244, A.245, F.258, T.259, G.260, S.261, V.264, I.268, E.288, T.289, G.290, C.322, E.417, F.419, L.445, F.485
- Ligands: ACT.25
17 PLIP interactions:17 interactions with chain C- Hydrophobic interactions: C:I.189, C:T.259
- Hydrogen bonds: C:A.181, C:A.181, C:W.183, C:K.207, C:E.210, C:G.240, C:E.241, C:S.261, C:T.289, C:E.417
- Water bridges: C:W.183, C:S.261, C:G.290, C:E.417, C:E.417
NAD.39: 29 residues within 4Å:- Chain D: I.180, A.181, P.182, W.183, N.184, I.189, K.207, P.208, A.209, E.210, G.240, E.241, G.244, A.245, F.258, T.259, G.260, S.261, V.264, I.268, E.288, T.289, G.290, C.322, E.417, F.419, L.445, F.485
- Ligands: ACT.35
18 PLIP interactions:18 interactions with chain D- Hydrophobic interactions: D:I.189, D:T.259
- Hydrogen bonds: D:A.181, D:A.181, D:W.183, D:K.207, D:E.210, D:G.240, D:S.261, D:T.289, D:E.417
- Water bridges: D:E.241, D:S.261, D:K.267, D:K.267, D:E.288, D:E.288, D:G.290
NAD.51: 29 residues within 4Å:- Chain E: I.180, A.181, P.182, W.183, N.184, I.189, K.207, P.208, A.209, E.210, G.240, E.241, G.244, A.245, F.258, T.259, G.260, S.261, V.264, I.268, E.288, T.289, G.290, C.322, E.417, F.419, L.445, F.485
- Ligands: ACT.48
17 PLIP interactions:17 interactions with chain E- Hydrophobic interactions: E:I.189, E:T.259
- Hydrogen bonds: E:A.181, E:A.181, E:W.183, E:K.207, E:E.210, E:G.240, E:E.241, E:S.261, E:T.289, E:E.417
- Water bridges: E:W.183, E:S.261, E:G.290, E:E.417, E:E.417
NAD.62: 29 residues within 4Å:- Chain F: I.180, A.181, P.182, W.183, N.184, I.189, K.207, P.208, A.209, E.210, G.240, E.241, G.244, A.245, F.258, T.259, G.260, S.261, V.264, I.268, E.288, T.289, G.290, C.322, E.417, F.419, L.445, F.485
- Ligands: ACT.58
18 PLIP interactions:18 interactions with chain F- Hydrophobic interactions: F:I.189, F:T.259
- Hydrogen bonds: F:A.181, F:A.181, F:W.183, F:K.207, F:E.210, F:G.240, F:S.261, F:T.289, F:E.417
- Water bridges: F:E.241, F:S.261, F:K.267, F:K.267, F:E.288, F:E.288, F:G.290
- 39 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
MPD.6: 4 residues within 4Å:- Chain A: V.312, Y.315, G.316, D.359
Ligand excluded by PLIPMPD.7: 6 residues within 4Å:- Chain A: F.6, Y.144, R.147, A.148, L.500
- Chain B: E.158
Ligand excluded by PLIPMPD.8: 4 residues within 4Å:- Chain A: Y.154, F.170
- Chain B: R.462
- Chain D: P.94
Ligand excluded by PLIPMPD.9: 5 residues within 4Å:- Chain A: R.36, Y.38, P.39, W.46, E.221
Ligand excluded by PLIPMPD.10: 6 residues within 4Å:- Chain A: L.275, G.278, Q.279, T.280
- Chain B: P.442, L.490
Ligand excluded by PLIPMPD.11: 5 residues within 4Å:- Chain A: R.151, A.156, Y.171, L.500
- Ligands: MPD.17
Ligand excluded by PLIPMPD.17: 6 residues within 4Å:- Chain B: R.151, Y.152, A.156, Y.171, L.500
- Ligands: MPD.11
Ligand excluded by PLIPMPD.18: 6 residues within 4Å:- Chain A: E.158
- Chain B: F.6, Y.144, R.147, A.148, L.500
Ligand excluded by PLIPMPD.19: 4 residues within 4Å:- Chain A: R.462
- Chain B: Y.154, F.170
- Chain E: P.94
Ligand excluded by PLIPMPD.20: 3 residues within 4Å:- Chain B: P.353, E.355, E.356
Ligand excluded by PLIPMPD.21: 5 residues within 4Å:- Chain A: P.442
- Chain B: L.275, G.278, Q.279, T.280
Ligand excluded by PLIPMPD.22: 4 residues within 4Å:- Chain B: R.36, Y.38, W.46, E.221
Ligand excluded by PLIPMPD.23: 4 residues within 4Å:- Chain B: V.312, Y.315, G.316, D.359
Ligand excluded by PLIPMPD.29: 4 residues within 4Å:- Chain C: V.312, Y.315, G.316, D.359
Ligand excluded by PLIPMPD.30: 6 residues within 4Å:- Chain C: F.6, Y.144, R.147, A.148, L.500
- Chain D: E.158
Ligand excluded by PLIPMPD.31: 4 residues within 4Å:- Chain C: Y.154, F.170
- Chain D: R.462
- Chain F: P.94
Ligand excluded by PLIPMPD.32: 5 residues within 4Å:- Chain C: R.36, Y.38, P.39, W.46, E.221
Ligand excluded by PLIPMPD.33: 6 residues within 4Å:- Chain C: L.275, G.278, Q.279, T.280
- Chain D: P.442, L.490
Ligand excluded by PLIPMPD.34: 5 residues within 4Å:- Chain C: R.151, A.156, Y.171, L.500
- Ligands: MPD.40
Ligand excluded by PLIPMPD.40: 6 residues within 4Å:- Chain D: R.151, Y.152, A.156, Y.171, L.500
- Ligands: MPD.34
Ligand excluded by PLIPMPD.41: 6 residues within 4Å:- Chain C: E.158
- Chain D: F.6, Y.144, R.147, A.148, L.500
Ligand excluded by PLIPMPD.42: 4 residues within 4Å:- Chain A: P.94
- Chain C: R.462
- Chain D: Y.154, F.170
Ligand excluded by PLIPMPD.43: 3 residues within 4Å:- Chain D: P.353, E.355, E.356
Ligand excluded by PLIPMPD.44: 5 residues within 4Å:- Chain C: P.442
- Chain D: L.275, G.278, Q.279, T.280
Ligand excluded by PLIPMPD.45: 4 residues within 4Å:- Chain D: R.36, Y.38, W.46, E.221
Ligand excluded by PLIPMPD.46: 4 residues within 4Å:- Chain D: V.312, Y.315, G.316, D.359
Ligand excluded by PLIPMPD.52: 4 residues within 4Å:- Chain E: V.312, Y.315, G.316, D.359
Ligand excluded by PLIPMPD.53: 6 residues within 4Å:- Chain E: F.6, Y.144, R.147, A.148, L.500
- Chain F: E.158
Ligand excluded by PLIPMPD.54: 4 residues within 4Å:- Chain B: P.94
- Chain E: Y.154, F.170
- Chain F: R.462
Ligand excluded by PLIPMPD.55: 5 residues within 4Å:- Chain E: R.36, Y.38, P.39, W.46, E.221
Ligand excluded by PLIPMPD.56: 6 residues within 4Å:- Chain E: L.275, G.278, Q.279, T.280
- Chain F: P.442, L.490
Ligand excluded by PLIPMPD.57: 5 residues within 4Å:- Chain E: R.151, A.156, Y.171, L.500
- Ligands: MPD.63
Ligand excluded by PLIPMPD.63: 6 residues within 4Å:- Chain F: R.151, Y.152, A.156, Y.171, L.500
- Ligands: MPD.57
Ligand excluded by PLIPMPD.64: 6 residues within 4Å:- Chain E: E.158
- Chain F: F.6, Y.144, R.147, A.148, L.500
Ligand excluded by PLIPMPD.65: 4 residues within 4Å:- Chain C: P.94
- Chain E: R.462
- Chain F: Y.154, F.170
Ligand excluded by PLIPMPD.66: 3 residues within 4Å:- Chain F: P.353, E.355, E.356
Ligand excluded by PLIPMPD.67: 5 residues within 4Å:- Chain E: P.442
- Chain F: L.275, G.278, Q.279, T.280
Ligand excluded by PLIPMPD.68: 4 residues within 4Å:- Chain F: R.36, Y.38, W.46, E.221
Ligand excluded by PLIPMPD.69: 4 residues within 4Å:- Chain F: V.312, Y.315, G.316, D.359
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Inagaki, E. et al., Crystal Structure Analysis of delta1-pyrroline-5-carboxylate dehydrogenase in ternary complex with inhibitor and NAD. To be Published
- Release Date
- 2007-09-11
- Peptides
- 1-pyrroline-5-carboxylate dehydrogenase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x NA: SODIUM ION(Non-functional Binders)
- 12 x ACT: ACETATE ION(Non-functional Binders)
- 6 x SER: SERINE(Non-covalent)
- 6 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 39 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Inagaki, E. et al., Crystal Structure Analysis of delta1-pyrroline-5-carboxylate dehydrogenase in ternary complex with inhibitor and NAD. To be Published
- Release Date
- 2007-09-11
- Peptides
- 1-pyrroline-5-carboxylate dehydrogenase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B